Publication:
Iron in kidney and heart failure: from theory to practice

dc.contributor.coauthorAfsar, Baris
dc.contributor.coauthorVoroneanu, Luminita
dc.contributor.coauthorSiriopol, Dimitire
dc.contributor.coauthorCovic, Adrian
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAslan, Gamze
dc.contributor.kuauthorBülbül, Mustafa Cem
dc.contributor.kuauthorDağel, Tuncay
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuauthorYerlikaya, Aslıhan
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.date.accessioned2024-11-09T23:58:51Z
dc.date.issued2018
dc.description.abstractThere is evidence that serum iron levels, regardless of the presence of anemia, directly impact outcomes in congestive heart failure (CHF) including quality of life, hospitalization rate and overall survival. Despite modern medical treatments, the prognosis of CHF remains grim. Ironically, simple iron replenishment may serve as a powerful tool in the armamentarium. This review will start from fundamental concepts of iron in oxygen delivery and analyze evidence-based outcomes in CHF iron-directed therapeutic trials. Imaging rationale that dovetails with this pathophysiology will also be detailed in a clinician-directed fashion.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume50
dc.identifier.doi10.1007/s11255-017-1708-6
dc.identifier.eissn1573-2584
dc.identifier.issn0301-1623
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85029758938
dc.identifier.urihttps://doi.org/10.1007/s11255-017-1708-6
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15540
dc.identifier.wos427128300013
dc.keywordsKidney disease
dc.keywordsHeart failure
dc.keywordsIron deficiency
dc.keywordsIron replacement
dc.keywordsIntravenous ferric carboxymaltose
dc.keywordsInflammatory mediators
dc.keywordsStimulating agents
dc.keywordsDeficiency anemia
dc.keywordsOxidative stress
dc.keywordsFair-Hf
dc.keywordsDisease
dc.keywordsDysfunction
dc.keywordsErythropoietin
dc.keywordsTrial
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofInternational Urology and Nephrology
dc.subjectUrology
dc.subjectNephrology
dc.titleIron in kidney and heart failure: from theory to practice
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorYerlikaya, Aslıhan
local.contributor.kuauthorBülbül, Mustafa Cem
local.contributor.kuauthorDağel, Tuncay
local.contributor.kuauthorAslan, Gamze
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files